Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
DCPH

Deciphera

$23.07

1.56 (7.25%)

07:25
06/18/19
06/18
07:25
06/18/19
07:25
Conference/Events
Deciphera to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

Friday
DCPH

Deciphera

$23.05

0.91 (4.11%)

07:19
06/14/19
06/14
07:19
06/14/19
07:19
Conference/Events
Deciphera to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

Over a week ago
DCPH

Deciphera

$21.57

-0.37 (-1.69%)

, ZLAB

Zai Lab

$28.50

0.62 (2.22%)

07:14
06/11/19
06/11
07:14
06/11/19
07:14
Hot Stocks
Deciphera, Zai Lab announce exclusive license agreement for ripretinib »

Deciphera Pharmaceuticals…

DCPH

Deciphera

$21.57

-0.37 (-1.69%)

ZLAB

Zai Lab

$28.50

0.62 (2.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

  • 18

    Jun

DCPH

Deciphera

$21.57

-0.37 (-1.69%)

, ZLAB

Zai Lab

$28.50

0.62 (2.22%)

07:09
06/11/19
06/11
07:09
06/11/19
07:09
Hot Stocks
Deciphera, Zai Lab announce ripretinib license agreement in Greater China »

Deciphera (DCPH) and Zai…

DCPH

Deciphera

$21.57

-0.37 (-1.69%)

ZLAB

Zai Lab

$28.50

0.62 (2.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

  • 18

    Jun

DCPH

Deciphera

$21.76

-0.18 (-0.82%)

10:22
06/10/19
06/10
10:22
06/10/19
10:22
Recommendations
Deciphera analyst commentary at Piper Jaffray »

Piper Jaffray says a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

  • 18

    Jun

DCPH

Deciphera

$21.76

-0.18 (-0.82%)

10:20
06/10/19
06/10
10:20
06/10/19
10:20
Hot Stocks
Deciphera announces new cancer pipeline candidate, DCC-3116 »

Deciphera Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

  • 18

    Jun

DCPH

Deciphera

$22.77

-0.64 (-2.73%)

, BPMC

Blueprint Medicines

$75.97

-2.2 (-2.81%)

05:34
06/03/19
06/03
05:34
06/03/19
05:34
Recommendations
Deciphera, Blueprint Medicines analyst commentary at Piper Jaffray »

Deciphera price target…

DCPH

Deciphera

$22.77

-0.64 (-2.73%)

BPMC

Blueprint Medicines

$75.97

-2.2 (-2.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

  • 11

    Jun

  • 18

    Jun

DCPH

Deciphera

$24.51

0.95 (4.03%)

04:55
05/30/19
05/30
04:55
05/30/19
04:55
Conference/Events
Deciphera management to meet with Piper Jaffray »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 04

    Jun

  • 11

    Jun

DCPH

Deciphera

$23.56

0.03 (0.13%)

08:48
05/29/19
05/29
08:48
05/29/19
08:48
Conference/Events
Deciphera management to meet with Piper Jaffray »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 30

    May

  • 31

    May

  • 04

    Jun

  • 11

    Jun

DCPH

Deciphera

$23.53

0.04 (0.17%)

04:55
05/28/19
05/28
04:55
05/28/19
04:55
Conference/Events
Deciphera management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 29

    May

  • 30

    May

  • 31

    May

  • 11

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.